This study was designed to evaluate the influence of extracellular Mg on the antitumour efficiency of haematoporphyrin derivative (HpD)or chlorin-e¢ trimethyl ester (E6)-based photodynamic therapy (PDT). In vitro experiments showed that in a calcium/serum-free medium the addition of MgCl, (from 1 up to 5 mM) to Ehrlich ascites carcinoma (EAC) cells induced (as measured by trypan blue test) a 1.5-fold increase in HpD-PDT efficacy. Moreover, during the HpD-PDT the presence of MgCl, enhanced the inhibition of both glycolytic and dehydrogenase activity of EAC cells, stimulated the photo-oxidation of cellular proteins and lipids, which was associated with a more considerable decrease in the reduced glutathione content. In the experimental conditions, Mg itself was practically nontoxic towards the cells at all concentrations investigated. Nevertheless, at a physiological concentration (1 mM) of Mg**, only a weak (about 10%) increase in the rate of HpD-photosensitized inactivation of EAC cells was observed. The influence of extracellular Mg on the efficiency of PDT did not depend on the nature of the sensitizer used; the in vitro effects with E 6 were similar to those seen for HpD. However, in contrast to the in vitro experiments it was found that in vivo an elevated level of extracellular Mg increased essentially the viability of EAC cells pretreated (before intraperitoneal inoculation) with HpD-PDT. Although the exact molecular mechanisms are largely unknown, the in vivo results suggest that Mg is, most probably, a serum factor decreasing the antitumour efficiency of HpD-PDT.